J.B. WepoGuard Syrup
J.B. WepoGuard Syrup : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL24076073TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- JIN BIN CORPORATION SDN. BHD.
- Manufacturer
- J.B. PHARMACY GROUP SDN. BHD.
- Registration period starting
- 2024-07-04
- Published validity end
- 2029-07-04
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Eugenia caryophyllata | Eugenia caryophyllata[10.00 mg,1 ml] | Not identified |
| Alpinia officinarum | Alpinia officinarum[10.00 mg,1 ml] | Not identified |
| Foeniculum vulgare | Foeniculum vulgare[7.00 mg,1 ml] | Not identified |
| Citrus aurantium | Citrus aurantium[7.00 mg,1 ml] | Not identified |
| Evodia rutaecarpa | Evodia rutaecarpa[3.00 mg,1 ml] | Not identified |
| Cyperus rotundus | Cyperus rotundus[10.00 mg,1 ml] | Not identified |
| Paeonia lactiflora | Paeonia lactiflora[12.00 mg,1 ml] | Not identified |
| Coptis chinensis | Coptis chinensis[3.00 mg,1 ml] | Not identified |
| Fritillaria thunbergii | Fritillaria thunbergii[12.00 mg,1 ml] | Not identified |
| Amomum villosum | Amomum villosum[5.00 mg,1 ml] | Not identified |
| Glycyrrhiza uralensis | Glycyrrhiza uralensis[14.00 mg,1 ml] | Not identified |
| Pinellia ternata | Pinellia ternata[7.00 mg,1 ml] | Not identified |
| Honey | Honey[250 mg,1 ml] | Miel |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Eugenia caryophyllata[10.00 mg,1 ml],Alpinia officinarum[10.00 mg,1 ml],Foeniculum vulgare[7.00 mg,1 ml],Citrus aurantium[7.00 mg,1 ml],Evodia rutaecarpa[3.00 mg,1 ml],Cyperus rotundus[10.00 mg,1 ml],Paeonia lactiflora[12.00 mg,1 ml],Coptis chinensis[3.00 mg,1 ml],Fritillaria thunbergii[12.00 mg,1 ml],Amomum villosum[5.00 mg,1 ml],Glycyrrhiza uralensis[14.00 mg,1 ml],Pinellia ternata[7.00 mg,1 ml],Honey[250 mg,1 ml]
- Valid until
- 2029-07-04
- Registration date
- 2024-07-04
- Published description
- NATURAL PRODUCT
- Licence holder
- JIN BIN CORPORATION SDN. BHD.
- Producer
- J.B. PHARMACY GROUP SDN. BHD.
- Published name
- J.B. WepoGuard Syrup
- Published reference
- 2023112813411T
- Registration number
- MAL24076073TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL24076073TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Foeniculum vulgare
Read the warning, when it applies and the studies cited
BITTER FENNEL- FOENICULUM VULGARE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Essential oil and Tincture.
Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 29 November 2024
SWEET FENNEL -FOENICULUM VULGARE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Glycyrrhiza uralensis
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.